Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Platt

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
British Journal of Cancer|April 4, 2013
Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancerL E De Faveri, C D Hurst, F M Platt, et al.
Journal of Inherited Metabolic Disease|December 27, 2006
Severe endothelial dysfunction in the aorta of a mouse model of Fabry disease; partial prevention by N-butyldeoxynojirimycin treatmentT Heare, N J Alp, D A Priestman, et al.
Brain : a Journal of Neurology|March 5, 2003
Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosisM Jeyakumar, R Thomas, E Elliot-Smith, et al.
NMR in Biomedicine|October 6, 2005
MRS reveals additional hexose N-acetyl resonances in the brain of a mouse model for Sandhoff diseaseJ P Lowe, D J Stuckey, F R Awan, et al.
Journal of Inherited Metabolic Disease|October 27, 2004
Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher diseaseD Elstein, C Hollak, J M F G Aerts, et al.
Journal of Inherited Metabolic Disease|June 19, 2001
Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapyF M Platt, M Jeyakumar, U Andersson, et al.
Trials|January 23, 2021
A master protocol to investigate a novel therapy acetyl-L-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasiaT Fields, M Patterson, T Bremova-Ertl, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
British Journal of Cancer|April 4, 2013
Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancerL E De Faveri, C D Hurst, F M Platt, et al.
Journal of Inherited Metabolic Disease|December 27, 2006
Severe endothelial dysfunction in the aorta of a mouse model of Fabry disease; partial prevention by N-butyldeoxynojirimycin treatmentT Heare, N J Alp, D A Priestman, et al.
Brain : a Journal of Neurology|March 5, 2003
Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosisM Jeyakumar, R Thomas, E Elliot-Smith, et al.
NMR in Biomedicine|October 6, 2005
MRS reveals additional hexose N-acetyl resonances in the brain of a mouse model for Sandhoff diseaseJ P Lowe, D J Stuckey, F R Awan, et al.
Journal of Inherited Metabolic Disease|October 27, 2004
Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher diseaseD Elstein, C Hollak, J M F G Aerts, et al.
Journal of Inherited Metabolic Disease|June 19, 2001
Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapyF M Platt, M Jeyakumar, U Andersson, et al.
Trials|January 23, 2021
A master protocol to investigate a novel therapy acetyl-L-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasiaT Fields, M Patterson, T Bremova-Ertl, et al.
Pageof 5